GPT and metabolic dysfunction-associated steatotic liver disease: In this study, we also observed increased body weight, liver weight, blood lipids and serum ALT similar to the previous investigation.(21,22) As expected, soy isoflavone could slow down the progression of NAFLD by reducing liver index, ALT and improving liver structure histopathologically but not changing food consumption.